1. Home
  2. CCSI vs ABEO Comparison

CCSI vs ABEO Comparison

Compare CCSI & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consensus Cloud Solutions Inc.

CCSI

Consensus Cloud Solutions Inc.

HOLD

Current Price

$37.46

Market Cap

493.6M

Sector

Technology

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$7.30

Market Cap

399.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCSI
ABEO
Founded
2021
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
493.6M
399.5M
IPO Year
2022
2005

Fundamental Metrics

Financial Performance
Metric
CCSI
ABEO
Price
$37.46
$7.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$37.50
$20.00
AVG Volume (30 Days)
141.0K
1.6M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
165.16
EPS
1.30
N/A
Revenue
$349,696,000.00
$2,998,000.00
Revenue This Year
$3.33
$1,024.31
Revenue Next Year
$2.70
$145.42
P/E Ratio
$29.51
N/A
Revenue Growth
N/A
258.18
52 Week Low
$19.42
$4.00
52 Week High
$41.40
$7.54

Technical Indicators

Market Signals
Indicator
CCSI
ABEO
Relative Strength Index (RSI) 60.22 76.10
Support Level $35.92 $4.85
Resistance Level $41.40 N/A
Average True Range (ATR) 1.82 0.36
MACD -0.13 0.11
Stochastic Oscillator 42.65 97.27

Price Performance

Historical Comparison
CCSI
ABEO

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Share on Social Networks: